Therma Bright Inc. Announces Share Consolidation
Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces, subject to the approval of the TSX Venture Exchange (the "TSXV"), that it will be undertaking a consolidation (the "Consolidation") of its common shares on the basis of eight (8) pre-Consolidation common shares for one (1) post-Consolidation common share. The Company expects that the...
2025-06-11 6:30 AM EDT
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company") a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces that subject to the approval of the TSX Venture Exchange (the "TSXV"), the Company intends to amend the exercise price of an aggregate of 42,725,000 outstanding common share purchase warrants of the Company (the "Warrants") that were issued as part of the Company's private...
2025-06-05 7:12 AM EDT
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
Toronto, Ontario--(Newsfile Corp. - May 8, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to provide an update on the significant progress achieved at InStatin over the past few months, focused on the development of inhaled statin therapies for respiratory conditions.A key development at InStatin is the appointment of Professor Sir Peter Barnes as a strategic advisor. Sir...
2025-05-08 6:30 AM EDT
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
Toronto, Ontario--(Newsfile Corp. - April 24, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce the successful signing of a new customer, resulting in an initial purchase order for 200 units of its flagship Venowave VW5 product, ("Venowave"). This purchase order underscores the continued demand for Venowave and the strength of the Company's product offering despite a...
2025-04-24 7:35 AM EDT
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
Toronto, Ontario--(Newsfile Corp. - April 16, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to provide an update to address the potential impact of recent and evolving US tariff policies on our current manufacturing operations of Venowave in China, which serves the US market.The Company is actively reviewing the implications of recent tariff changes imposed by the US...
2025-04-16 6:30 AM EDT
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
Toronto, Ontario--(Newsfile Corp. - March 13, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that the Company has secured an exclusive U.S. contract for its consumer product devices with national marketing and distribution partner Global Wellness Products LLC, a subsidiary of Image Protect, Inc. — a United States Corporation publicly traded under the symbol (OTC Pink:...
2025-03-13 6:30 AM EDT
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the addition of Steve Raysely to its Advisory Board. With deep experience in healthcare and technology sales, marketing and operations, Mr. Raysely brings a wealth of expertise to the Company's growing advisory team.Steve Raysely is a distinguished senior executive and strategic advisor with over two...
2025-02-04 6:30 AM EST
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
Toronto, Ontario--(Newsfile Corp. - January 21, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that it has secured a purchase order for 1,750 Venowave VW5 from national distribution partner DME Authority of Nashville, Tennessee. DME, along with their partner network, was just one of the Company's national distributors who have experienced successful pilot trials....
2025-01-21 6:00 AM EST
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
Toronto, Ontario--(Newsfile Corp. - January 13, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that the Company has secured an initial purchase order for 100 Venowave VW5 units from a new national distribution partner Valor Medical Solutions of San Antonio, Texas. The initial purchase order is based on the success of the distributor's pilot tests...
2025-01-13 6:00 AM EST
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - January 9, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces that the Company has negotiated a debt settlement with arm's length creditor. Pursuant to the debt settlement it has arranged, and subject to acceptance by the TSXV, the Company proposes to settle aggregate debt of $100,000 in consideration for which it...
2025-01-09 5:27 PM EST
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - January 3, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces that the Company has negotiated a debt settlement with arm's length creditor. Pursuant to the debt settlement it has arranged, and subject to acceptance by the TSXV, the Company proposes to settle aggregate debt of $113,000 in consideration for which it...
2025-01-03 5:00 PM EST
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce the Company has signed a letter of intent (LOI) for a Venowave distribution program with DME Authority based in Nashville, TN. Through this distribution program, DME Authority will collaborate with multiple tenured and qualified network partners to establish no less than...
2024-12-18 6:30 AM EST
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase
Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, congratulates its investment partner Inretio on the success of the first phase of the PREVA™ ischemic stroke device. Per Inretio's LinkedIn post and formal press announcement, https://www.linkedin.com/posts/inretiomd_stroke-strokecare-medicalinnovation-activity-7272282195824705536-VsdS?utm_source=share&utm_medium=member_android key collaborator Dr. Gal Yaniv, Director of Endovascular Neurosurgery from Sheba Medical Center, presented compelling findings from th
2024-12-11 8:04 AM EST
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
Distributors' medical partner networks impressed with Venowave device, speed of Medicare/Medicaid processing and prepare roadmaps to drive salesToronto, Ontario--(Newsfile Corp. - December 5, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce that its nationwide U.S. distribution partners, along with several prospective new partners, have successfully secured Medicare and Medicaid HCPCS Level II code reimbursements within a...
2024-12-05 6:30 AM EST
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologies, has completed its announced strategic review, and has set the course to spin-off the Company's Consumer Product Portfolio into its own separate publicly traded company. This move is aimed at strengthening Therma Bright's strategic and operational focus, capitalizing on growth opportunities, and unlocking shareholder value.Both companies are expected to maintain a strong...
2024-11-18 6:00 AM EST
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - November 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces that the Company has negotiated debt settlements with arm's length creditors. Pursuant to the debt settlements it has arranged, and subject to acceptance by the TSXV, the Company proposes to settle aggregate debt of $297,326.50 in consideration for which it will...
2024-11-11 5:00 PM EST
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions
Toronto, Ontario--(Newsfile Corp. - October 28, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce a significant development with its investment partners, InStatin and InVixa. InVixa will assign its licensing agreement to InStatin, contingent upon approval from the University of California, Davis.The collaboration marks a pivotal step in the integration of these two businesses. This strategic move of InVixa assigning InStatin with...
2024-10-28 7:00 AM EDT
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces further to its press release of September 18, 2024, it has now issued an aggregate of 5,056,250 common shares at a deemed price of $0.08 per share to settle aggregate debt of $404,500.All shares issued in relation to these debt...
2024-10-18 5:00 PM EDT
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release
Therma Bright Closes First Tranche of Non-Brokered Concurrent Private Placement for CAD $174,900Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that its nationwide U.S. medical device distribution partner as Quantify Medical as previously announced on August 22, 2024. Quantify Medical has witnessed promising preliminary success with...
2024-10-10 6:30 AM EDT
Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million
Toronto, Ontario--(Newsfile Corp. - September 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that it will be conducting a non-brokered listed issuer financing exemption (LIFE) private placement of up to CAD$3,000,000 through the issuance of up to 50,000,000 common shares of the Company at a price of CAD$0.06 per share (the "LIFE...
2024-09-27 6:00 AM EDT